COMPUGEN (CGEN) Covered Calls

COMPUGEN covered calls Compugen, Ltd. engages in drug and diagnostic product candidate discovery and commercialization of such candidates largely through early stage licensing and development agreements.

You can sell covered calls on COMPUGEN to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CGEN (prices last updated Mon 4:16 PM ET):

COMPUGEN (CGEN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.55 +0.20 3.50 3.60 337K - 0.2B
Covered Calls For COMPUGEN (CGEN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 2.5 0.00 3.60 -30.6% -2233.8%
Nov 16 2.5 0.70 2.90 -13.8% -152.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Tel Aviv, Israel.